← SynDRA
EZOBRESIB
SynDRA canonical compound SYN0039606 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | BRD2 | BRD3 | BRD4 | BRDT |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BRD2 INHIBITOR
- Bromodomain and extra-terminal motif (BET) inhibitor
- BET bromodomain inhibitor
- BRDT INHIBITOR
- BRD3 INHIBITOR
Cross-references
Synonyms
- Bet inhibitor bms-986158
- BMS-986158
- KGERZPVQIRYWRK-GDLZYMKVSA-N
- UNII-X8BW0MQ5PI
- X8BW0MQ5PI
- SCHEMBL16861831
- EX-A2678
- CS-7497
- HY-101567
- (S)-2-(3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-(phenyl(tetrahydro-2H-pyran-4-yl)methyl)-5H-pyrido[3,2-b]indol-7-yl)propan-2-ol
- Bms-986158
- Bet inhibitor BMS-986158
- BMS986158
- compound 18 [PMID: 34543572]
- compound 18 (PMID: 34543572)
- RefChem:120771
- Ezobresib (USAN)
- EZOBRESIB [USAN]
- BDBM297146
- ezobresib [INN]
- MFCD31544327
- orb1308546
- SCHEMBL29430379
- SCHEMBL29631072
- GTPL11757
- BDBM296947
- C30H33N5O2
- AXC34040
- US10112941, Example 54
- US10112941, Example 90
- NSC801230
- BMS 986158 [WHO-DD]
- US10112941, Example 262
- AKOS040741393
- NSC-801230
- NCGC00521941-02
- AC-36650
- DA-71596
- MS-29213
Look up EZOBRESIB in the interactive SynDRA portal →